Keyphrases
Angiogenesis
100%
Glycine
100%
Vascular Endothelial Growth Factor Signaling
100%
Vascular Endothelial Growth Factor
42%
Voltage-dependent Anion Channel 1 (VDAC1)
28%
Glycine Transporter
28%
Molecular Mechanism
14%
Clinical Trials
14%
Full Potential
14%
Amino Acids
14%
Mammalian Target of Rapamycin (mTOR)
14%
Vascular Disease
14%
Angiogenic
14%
Ischemic Tissue
14%
Novel Therapeutic Targets
14%
Mechanistic Insight
14%
Peripheral Arterial Disease
14%
Blood Perfusion
14%
Mitochondrial Function
14%
Ischemic Disease
14%
Mitochondrial Outer Membrane
14%
Information for Development
14%
Therapeutic Angiogenesis
14%
Biochemistry, Genetics and Molecular Biology
Angiogenesis
100%
Vascular Endothelial Growth Factor
100%
Growth Factor Signaling
100%
Voltage-Dependent Anion Channel
28%
Glycine Transporter 1
28%
Amino Acids
14%
Perfusion
14%
Clinical Trial
14%
Mediator
14%
Mammalian Target of Rapamycin
14%
Outer Mitochondrial Membrane
14%
Medicine and Dentistry
Angiogenesis
100%
Vasculotropin
100%
Glycine Transporter 1
28%
Voltage Dependent Anion Channel 1
28%
In Vitro
14%
Clinical Trial
14%
Amino Acid
14%
Vascular Disease
14%
Side Effect
14%
Atherosclerosis
14%
Ischemia
14%
Mediator
14%
Arteriosclerosis Obliterans
14%
Mammalian Target of Rapamycin
14%
Outer Membrane
14%
Neuroscience
Angiogenesis
100%
Vascular Endothelial Growth Factor
100%
Voltage Dependent Anion Channel 1
28%
Glycine Transporter 1
28%
In Vivo
14%
In Vitro
14%
Amino Acid
14%
Vascular Disease
14%
Mitochondrial Function
14%
Outer Membrane
14%
Ischemia
14%
Pharmacology, Toxicology and Pharmaceutical Science
Vasculotropin
100%
Voltage Dependent Anion Channel 1
40%
Glycine Transporter 1
40%
Amino Acid
20%
Clinical Trial
20%
Side Effect
20%
Atherosclerosis
20%
Ischemia
20%
Vascular Disease
20%
Peripheral Occlusive Artery Disease
20%